Skip to main content
. 2022 Feb 9;12(2):281. doi: 10.3390/biom12020281

Figure 3.

Figure 3

IOP in C57BL/6J mice following injection of Ad5myoc into the anterior chamber. (A) IOP profile of treatment groups. Pioglitazone treatment was initiated either 4 weeks (red arrow) or 12 weeks (blue arrow) after induction of elevated IOP. (B) Average cumulative IOP in treatment groups. No significant differences in cumulative IOP were observed between Ad5myoc-injected mice (p > 0.25).